NAA drug
Evidence from:
primary |
all sources
Related entities (11)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| NAA | biomarker_for | alcoholism | — | 1 |
| NAA | expressed_in | brain white matter | — | 1 |
| NAA | expressed_in | cerebellar vermis | — | 1 |
| NAA | expressed_in | cerebellum | — | 2 |
| NAA | expressed_in | dorsolateral prefrontal cortex | — | 1 |
| NAA | expressed_in | frontal cortex | — | 1 |
| NAA | associated_with | frontocerebellar circuitry | — | 1 |
| NAA | expressed_in | gray matter | — | 2 |
| NAA | biomarker_for | neuronal integrity | — | 1 |
| NAA | biomarker_for | relapse | — | 1 |
| NAA | expressed_in | thalamus | — | 1 |
Mentioned in (29)
Papers in which this entity is mentioned.
- H-MRS neurometabolite profiles and motor development in school-aged children who are HIV-exposed uninfected: a birth cohort study. (2023)
- A Neurometabolic Pattern of Elevated Myo-Inositol in Children Who Are HIV-Exposed and Uninfected: A South African Birth Cohort Study. (2022)
- Functional Connectivity and Metabolic Alterations in Medial Prefrontal Cortex in a Rat Model of Fetal Alcohol Spectrum Disorder: A Resting-State Functional Magnetic Resonance Imaging and in vivo Proton Magnetic Resonance Spectroscopy Study. (2019)
- Challenges in pediatric neuroimaging. (2019)
- Perinatal HIV Infection or Exposure Is Associated With Low -Acetylaspartate and Glutamate in Basal Ganglia at Age 9 but Not 7 Years. (2018)
- Altered brain morphometry in 7-year old HIV-infected children on early ART. (2018)
- Alcohol's Effects on the Brain: Neuroimaging Results in Humans and Animal Models. (2017)
- An in vivo 1H magnetic resonance spectroscopy study of the deep cerebellar nuclei in children with fetal alcohol spectrum disorders. (2014)
- A comparison of spectral quality in magnetic resonance spectroscopy data acquired with and without a novel EPI-navigated PRESS sequence in school-aged children with fetal alcohol spectrum disorders. (2014)
- Quality of 186 child brain spectra using motion and B0 shim navigated single voxel spectroscopy. (2014)
- Genetic influences on brain developmental trajectories on neuroimaging studies: from infancy to young adulthood. (2014)
- Bridging animal and human models of exercise-induced brain plasticity. (2013)
- Real-time motion and B0 correction for localized adiabatic selective refocusing (LASER) MRSI using echo planar imaging volumetric navigators. (2012)
- The neural effects of psychotropic medications in children and adolescents. (2012)
- Caudate volume predicts neurocognitive performance in youth with heavy prenatal alcohol exposure. (2012)
- Relating MEG measured motor cortical oscillations to resting γ-aminobutyric acid (GABA) concentration. (2011)
- Magnetic resonance-based imaging in animal models of fetal alcohol spectrum disorder. (2011)
- Focus on: magnetic resonance-based studies of fetal alcohol spectrum disorders in animal models. (2011)
- Focus on: structural and functional brain abnormalities in fetal alcohol spectrum disorders. (2011)
- A novel phase and frequency navigator for proton magnetic resonance spectroscopy using water-suppression cycling. (2011)
- The neuronal transporter gene SLC6A15 confers risk to major depression. (2011)
- Contributions of studies on alcohol use disorders to understanding cerebellar function. (2010)
- Quantification of ethanol methyl (1)H magnetic resonance signal intensity following intravenous ethanol administration in primate brain. (2010)
- Prospective motion correction for single-voxel 1H MR spectroscopy. (2010)
- In vivo magnetic resonance spectroscopy: basic methodology and clinical applications. (2010)
- Structural, metabolic, and functional brain abnormalities as a result of prenatal exposure to drugs of abuse: evidence from neuroimaging. (2010)
- Magnetic resonance spectroscopy outcomes from a comprehensive magnetic resonance study of children with fetal alcohol spectrum disorders. (2009)
- Neuroimaging of children following prenatal drug exposure. (2009)
- Neuroimaging and fetal alcohol spectrum disorders. (2009)
Merged raw entities (1)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| naa | drug | 29 | 86 |